Bach Ardalan
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 31
- Pancreatic and Hepatic Oncology Research 13
- Cancer Treatment and Pharmacology 13
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 10
-
- Gastric Cancer Management and Outcomes 18
- Cancer Research top 10%
-
- Biochemical and Molecular Research 17
- Cancer therapeutics and mechanisms 10
-
- Esophageal Cancer Research and Treatment 9
- Co-authors
- Pochi R. SubbarayanRobert I. GlazerHoward SilbermanAlan S. LivingstoneThomas R. FlemingHiremagalur N. JayaramRandall F. HolcombeA Mangalik
- Journals
- Journal of Clinical Oncology (15 papers)Cancer (6 papers)Biochemical Pharmacology (4 papers)
- Partner nations
- United StatesChileUnited Kingdom
In The Last Decade
Bach Ardalan
100 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 102
- Oncology 1.1k
- Hepatology 147
- Pulmonary and Respiratory Medicine 453
- Pathology and Forensic Medicine 247
- Cancer Research 174
Countries citing papers authored by Bach Ardalan
This map shows the geographic impact of Bach Ardalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bach Ardalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bach Ardalan more than expected).
Fields of papers citing papers by Bach Ardalan
This network shows the impact of papers produced by Bach Ardalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bach Ardalan. The network helps show where Bach Ardalan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bach Ardalan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 10 | |
| 5 | 2015 | 8 | |
| 6 | 2014 | 48 | |
| 7 | Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU. | 2010 | 27 |
| 8 | 2007 | 13 | |
| 9 | 2006 | 35 | |
| 10 | Inhibition of RNA synthesis by 5-fluorouridine accounts for its cyto toxicity on colorectal cancer cells in vitro | 2005 | 1 |
| 11 | 2004 | 7 | |
| 12 | 2004 | 1 | |
| 13 | 2004 | 4 | |
| 14 | 2003 | 10 | |
| 15 | 1999 | 22 | |
| 16 | 1995 | 280 | |
| 17 | 1994 | 15 | |
| 18 | 1991 | 16 | |
| 19 | Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics. | 1988 | 36 |
| 20 | 1988 | 110 |
About Bach Ardalan
Bach Ardalan is a scholar working on Oncology, Hepatology and Cancer Research, having authored 105 papers that have together received 1.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (31 papers), Gastric Cancer Management and Outcomes (18 papers), Biochemical and Molecular Research (17 papers), Pancreatic and Hepatic Oncology Research (13 papers), Cancer Treatment and Pharmacology (13 papers), Cancer therapeutics and mechanisms (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Esophageal Cancer Research and Treatment (9 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (147 citations) and Pulmonary and Respiratory Medicine (453 citations). Bach Ardalan has collaborated with scholars based in United States, Chile and United Kingdom. Frequent co-authors include Pochi R. Subbarayan, Robert I. Glazer, Howard Silberman, Alan S. Livingstone, Thomas R. Fleming, Hiremagalur N. Jayaram, Randall F. Holcombe, A Mangalik, Frederick J. Meyers and Geoffrey R. Weiss. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Biochemical Pharmacology, Investigational New Drugs and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.